3H-Pyrazol-3-one,1,2-dihydro-1,5-dimethyl-4-(1-methylethyl)-2-phenyl- cas no:479-92-5
Synonyms: Antipyrine,4-isopropyl- (6CI,7CI,8CI);1,2-Dihydro-1,5-dimethyl-2-phenyl-4-isopropyl-3H-pyrazol-3-one;1-Phenyl-2,3-dimethyl-4-isopropyl-3-pyrazolin-5-one;1-Phenyl-2,3-dimethyl-4-isopropylpyrazol-5-one;4-Isopropyl-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one;4-Isopropylantipyrine;4-Isopropylphenazone;Arantil P;Budirol;Causyth;Cibalgina;Eufibron;Isopropchin;Isopropylantipyrin;Isopropylantipyrine;Isopropylphenazone;Isopropyrine;Larodon;
Name3H-Pyrazol-3-one,1,2-dihydro-1,5-dimethyl-4-(1-methylethyl)-2-phenyl-
CAS479-92-5
SynonymsAntipyrine,4-isopropyl- (6CI,7CI,8CI);1,2-Dihydro-1,5-dimethyl-2-phenyl-4-isopropyl-3H-pyrazol-3-one;1-Phenyl-2,3-dimethyl-4-isopropyl-3-pyrazolin-5-one;1-Phenyl-2,3-dimethyl-4-isopropylpyrazol-5-one;4-Isopropyl-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one;4-Isopropylantipyrine;4-Isopropylphenazone;Arantil P;Budirol;Causyth;Cibalgina;Eufibron;Isopropchin;Isopropylantipyrin;Isopropylantipyrine;Isopropylphenazone;Isopropyrine;Larodon;
EINECS(EC#)207-539-2
Molecular FormulaC14H18N2O
Molecular Weight230.34
Appearancesolid
refractive index1.555
storage tempRefrigerator
Risk R36/37/38
Safety
A poison by ingestion and intraperitoneal routes. When heated to decomposition it emits toxic fumes of NOx.
Risk Statements: 36/37/38
36/37/38: Irritating to eyes, respiratory system and skin
Safety Statements: 26-36/37/39
26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice
36/37/39: Wear suitable protective clothing, gloves and eye/face protection
RTECS: CD2800000 .
1. |
|
orl-rat LD50:860 mg/kg
|
|
YKKZAJ Yakugaku Zasshi. Journal of Pharmacy. 97 (1977),601. |
2. |
|
orl-mus LD50:960 mg/kg
|
|
ARZNAD Arzneimittel-Forschung. Drug Research. 9 (1959),401. |
3. |
|
ipr-mus LD50:295 mg/kg
|
|
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. 122 (1959),434. |
4. |
|
orl-cat LDLo:150 mg/kg
|
|
JPETAB Journal of Pharmacology and Experimental Therapeutics. 61 (1937),205. |
5. |
|
orl-rbt LDLo:500 mg/kg
|
|
JPETAB Journal of Pharmacology and Experimental Therapeutics. 61 (1937),205. |
6. |
|
orl-gpg LD50:1050 mg/kg
|
|
SMWOAS Schweizerische Medizinische Wochenschrift. 84 (1954),351. |